Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

AbbVie could end up sidestepping lost sales tied to an expiring patent on Humira in 2017
Motley Fool
Sun, 08/23/15 - 11:40 am
Tags:
AbbVie, Humira, patents, Imbruvica, autoimmune disease
Baxalta Vs. AbbVie: Biopharma Spin-Off Battle
Seeking Alpha
Sat, 08/22/15 - 08:53 am
Tags:
spinoffs, AbbVie, Abbott Labs, Baxalta, Baxter
Why Four Months Is Worth $350m To AbbVie And Filgotinib
Seeking Alpha
Fri, 08/21/15 - 05:19 pm
Tags:
AbbVie, filgotinib, FDA, review vouchers, priority review
Did AbbVie Just Make an Incredibly Brilliant Decision?
Motley Fool
Fri, 08/21/15 - 09:31 am
Tags:
AbbVie, priority review, review vouchers, United Therapeutics
AbbVie Inc May Use Priority Voucher To Gain Lymphoma Lead Over Roche
Bidness, ETC
Thu, 08/20/15 - 11:53 am
Tags:
AbbVie, priority review, Roche, CLL, chronic lymphocytic leukemia, United Therapeutics
AbbVie buys special review voucher for $350 mln
Yahoo/Reuters
Wed, 08/19/15 - 12:25 pm
Tags:
AbbVie, priority review, review vouchers, United Therapeutics
4 Top Pharma Stocks That Should Outperform Out To 2016
24/7 Wall St
Tue, 08/18/15 - 09:44 am
Tags:
AbbVie, Bristol-Myers Squibb, Eli Lilly, Merck
AbbVie Challenges Fairness Of Upcoming Testosterone Trials
Forbes
Mon, 08/17/15 - 07:18 pm
Tags:
AbbVie, testosterone, Androgel
AbbVie And Amgen Threatened By Biosimilars
Bidness, ETC
Mon, 08/17/15 - 07:57 am
Tags:
AbbVie, Amgen, biosimilars, JNJ, Sandoz, Novartis, Humira, Neupogen, Remicade, Nuelasta, Enbrel, epoetin-alfa
Galapagos starts timer on AbbVie buy-in decision with posting of final data
Fierce Biotech
Fri, 08/14/15 - 09:20 am
Tags:
Galapagos, AbbVie, JAK inhibitors, rheumatoid arthritis, filgotinib
AbbVie Inc Cancer Drug Holds Blockbuster Potential
Bidness, ETC
Wed, 08/12/15 - 10:11 pm
Tags:
AbbVie, CLL, Roche, venetoclax
AbbVie to seek FDA approval for leukemia drug after trial success
Yahoo/Reuters
Wed, 08/12/15 - 10:35 am
Tags:
AbbVie, FDA, Roche, chronic lymphocytic leukemia, CLL, venetoclax
Why AbbVie Should Be Worth 25 Percent More
24/7 Wall St
Mon, 08/10/15 - 09:20 pm
Tags:
AbbVie
Galapagos peaks as AbbVie hype builds, Shorts target Bavarian, MorphoSys makes GPCR play
Fierce Biotech
Fri, 08/7/15 - 10:44 am
Tags:
Galapagos, AbbVie, Bavarian Nordic, Intec Pharma, MorphoSys
Merck Targets Toughest Cases to Gain Hepatitis C Foothold
Bloomberg
Mon, 08/3/15 - 05:10 pm
Tags:
Merck, Gilead Sciences, AbbVie, hepatitis C, Viekira Pak, Harvoni, Sovaldi, grazoprevir/elbasvir
New drug approval is a win for the Bay State's horse in the hepatitis C race
Bizjournals.com
Tue, 07/28/15 - 12:34 pm
Tags:
Enanta Pharmaceuticals, AbbVie, Technivie, hepatitis C
AbbVie, Bristol-Myers get FDA nod for hep C treatments
Yahoo/Reuters
Fri, 07/24/15 - 05:40 pm
Tags:
AbbVie, Bristol-Myers Squibb, hepatitis C, FDA, Technivie, Daklinza
AbbVie reports first revenue miss in six quarters
Yahoo/Reuters
Fri, 07/24/15 - 10:07 am
Tags:
AbbVie, earnings
What to Expect From AbbVie Earnings
Yahoo/24 7 Wall St
Thu, 07/23/15 - 11:05 pm
Tags:
AbbVie, earnings
Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
Fierce Pharma Marketing
Wed, 07/22/15 - 09:36 pm
Tags:
biosimilars, AbbVie, Roche, Amgen, Rituxan, Herceptin, Avastin, Neupogen, Neulasta, Epogen, Humira, Perjeta, Gazyva

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.